The FDA previously authorized the use of an eye drop formulated to eliminate reading glasses.
A Mumbai-based pharmaceutical corporation declared openly on Tuesday that it is in the final stages of developing an eye drop that could change the lives of millions with age-related blurred concepts. The situation, known as presbyopia, is the incremental loss of the eye’s ability to focus on close objects and it usually causes people mostly over 40 years of age.
The pharma company acknowledges that these eye drops have been indicated to modify close-up vision within 15 minutes, with one drop in each eye providing sharper vision for 6 to 10 hours. Clinical studies achieved worldwide have also shown encouraging results in the US.
“These eye drops, called PresVu, would be the first of its kind in India to treat presbyopia to be developed by our DSIR-approved laboratory. Detailed findings from studies and clinical trials would soon be presented to the DCGI to initiate the regulatory approval process in India. Following approval, we intend to manufacture these eye drops under the Make in India initiative and launch them across the country and worldwide at an affordable price. We intend to make this eye drop available as a less expensive alternative to spectacles,” ENTOD Pharmaceuticals CEO Nikkhil K Masurkar said in a statement on Tuesday.
The company also claims that PresVu Eye Drops can utilise the eye’s natural proficiency to lower its pupil size.
